Raphael Bernier is professor of psychiatry at the University of Washington and clinical director of the Seattle Children’s Autism Center.
Raphael Bernier
Assistant Professor
University of Washington, Seattle
From this contributor
Through play, children with autism can hone thinking skills
Clinicians can use play to deliver therapies that could improve a child’s social skills, language and certain cognitive capacities.
Through play, children with autism can hone thinking skills
By
Raphael Bernier
31 May 2016 | 6 min read
Best practices
Guidelines for the use of electroencephalography in autism will ensure that researchers have a common set of standards, which will speed up discovery, say Sara Jane Webb and Raphael Bernier.
How do we measure autism severity?
Accurately measuring the severity of autism remains a challenge for the field. The answer may lie in using more than one approach that varies depending on whether it is being applied in a clinical or research context, says Raphael Bernier.
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read